4.4 Review

Dysregulation of microRNA biogenesis machinery in cancer

出版社

TAYLOR & FRANCIS LTD
DOI: 10.3109/10409238.2015.1117054

关键词

Argonaute; DGCR8; Dicer; Drosha; microRNA; post-translational modifications; pre-miRNA; pri-miRNA; processing; stability; TRBP

资金

  1. LeDucq Transatlantic Network of Excellence in Cardiovascular Research Program
  2. National Institutes of Health (NIH) [HL108317, HL116191]
  3. NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL116191, R01HL108317] Funding Source: NIH RePORTER

向作者/读者索取更多资源

MicroRNAs (miRNAs) are integral to the gene regulatory network. A single miRNA is capable of controlling the expression of hundreds of protein coding genes and modulate a wide spectrum of biological functions, such as proliferation, differentiation, stress responses, DNA repair, cell adhesion, motility, inflammation, cell survival, senescence and apoptosis, all of which are fundamental to tumorigenesis. Overexpression, genetic amplification, and gain-of-function mutation of oncogenic miRNAs (onco-miRs) as well as genetic deletion and loss-of-function mutation of tumor suppressor miRNAs (suppressor-miRs) are linked to human cancer. In addition to the dysregulation of a specific onco-miR or suppressor-miRs, changes in global miRNA levels resulting from a defective miRNA biogenesis pathway play a role in tumorigenesis. The function of individual onco-miRs and suppressor-miRs and their target genes in cancer has been described in many different articles elsewhere. In this review, we primarily focus on the recent development regarding the dysregulation of the miRNA biogenesis pathway and its contribution to cancer.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据